GlassScriptPhysician profile
Erika P Hunter
NPI 1477647154
$30,249.58
in general payments reported to CMS, 2019-2025
17 companies · $1,019 in 2025
The $1,019 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $18K · 2021: $3,773 · 2022: $4,429 · 2023: $2,270 · 2024: $555 · 2025: $1,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,022 · Travel and Lodging: $1,592 · Education: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,021.56 |
| Travel and Lodging | $1,592.34 |
| Education | $229.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $23,568.28 | 2020-2025 | |
| Coloplast Corp | $2,223.18 | 2021-2023 | Altis |
| Axonics, INC. | $2,030.27 | 2021-2024 | Axonics, Bulkamid |
| Caldera Medical, INC | $492.64 | 2022-2025 | Desara |
| Abbvie INC. | $461.26 | 2022-2025 | |
| Boston Scientific Corporation | $326.09 | 2023-2025 | Bulkamid, Upsylon, Axonics |
| Astellas Pharma US INC | $301.05 | 2021-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $294.37 | 2025 | Gemtesa |
| Pfizer INC. | $164.36 | 2021-2022 | |
| Allergan, INC. | $88.27 | 2020-2021 | |
| Valencia Technologies Corporation | $76.36 | 2025 | Ecoin Device Kit |
| Convatec INC. | $70.80 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $61.18 | 2021-2023 | Xifaxan |
| Coopersurgical, INC. | $28.67 | 2025 | Ally II Ups |
| C. R. Bard, INC. & Subsidiaries | $22.04 | 2024 | Bard Urinary Drainage Bag |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $21.59 | 2021 | |
| Davol INC. | $19.17 | 2025 | Arista |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.